<html >
<head>
	<meta charset="UTF-8"></meta>
	<title></title>
    <style type="text/css">
        table{
        }
        /* Border styles */
        #table-1 thead, #table-1 tr {
            border-top-width: 1px;
            border-top-style: solid;
            border-top-color: rgb(230, 189, 189);
        }
        #table-1 {
            border-bottom-width: 1px;
            border-bottom-style: solid;
            border-bottom-color: rgb(230, 189, 189);
        }

        /* Padding and font style */
        #table-1 td, #table-1 th {
            padding: 5px 10px;
            font-size: 12px;
            font-family: Verdana;
            color: rgb(177, 106, 104);
        }

        /* Alternating background colors */
        #table-1 tr:nth-child(even) {
            background: rgb(238, 211, 210)
        }
        #table-1 tr:nth-child(odd) {
            background: #FFF
        }
        table.gridtable {
            font-family: verdana,arial,sans-serif;
            font-size:11px;
            color:#333333;
            border-width: 1px;
            border-color: #666666;
            border-collapse: collapse;
			padding-top: 1px;
			background: bisque;
        }
        table.gridtable th {
            border-width: 1px;
            padding: 8px;
            border-style: solid;
            border-color: #666666;
            background-color: burlywood;
        }
        table.gridtable td {
            border-width: 1px;
			height: 100px;
            padding: 2px;
            border-style: solid;
            border-color: #666666;
            background-color: #ffffff;
        }
        table.gridtable caption{
            text-align:left;
            padding-bottom:0;
            border-style: none;
        }
        #a1{
            font-size: 15px;
        }

        table.infotable{
            border-width: 1px;
            padding: 8px;
            border-collapse: collapse;
            border-style: solid;
            border-color: #666666;
            background-color: burlywood;
            font-family: verdana,arial,sans-serif;
        }

        #h2title {
            margin: 0px 200px 0px 200px;
            font-family: verdana,arial,sans-serif;
        }
    </style>

</head>
<body>


<div id="head_div">
    <h2 id="h2title" >基因检测报告</h2>
</div>
<br>
<br>
         <table_title > 患者信息</table_title>
		 <table  class="infotable" width="600">
                 <strong id="a1">姓名:&nbsp;&nbsp;&nbsp;</strong><a class="a2" >小明</a><br>
                 <strong id="a1">年龄:&nbsp;&nbsp;&nbsp;</strong><a class="a2">65</a><br>
                 <strong id="a1">性别:&nbsp;&nbsp;&nbsp;</strong><a class="a2">男</a><br>

		 </table>
<br>

         <table_title > 化疗药物</table_title>
		 <table  class="gridtable" width="600" border="1">
			 <tr>
				 <th align="left">疾病</th>
                 <th align="left" >药物</th>
                 <th align="left">基因</th>
                 <th align="left">rs</th>
                 <th align="left" >证据等级</th>
                 <th align="left">基因型</th>
                 <th align="left ">注释</th>
			 </tr>
		     <tr>
                 <td>Neoplasms (PA445062)</td>
                 <td>irinotecan (PA450085)</td>
                 <td>SLCO1B1 (PA134865839)</td>
                 <td>rs4149056</td>
                 <td>3</td>
                 <td>TT</td>
                 <td>毒副作用可能较低</td>
             </tr>
		     <tr>
                 <td>Colorectal Neoplasms (PA446108)</td>
                 <td>irinotecan (PA450085)</td>
                 <td>UGT1A9 (PA419)</td>
                 <td>rs11692021</td>
                 <td>3</td>
                 <td>TT</td>
                 <td>毒副作用可能较低</td>
             </tr>
		     <tr>
                 <td>Colorectal Neoplasms (PA446108)</td>
                 <td>irinotecan (PA450085)</td>
                 <td>ABCC1 (PA244)</td>
                 <td>rs3743527</td>
                 <td>3</td>
                 <td>CC</td>
                 <td>毒副作用可能较高</td>
             </tr>
		     <tr>
                 <td>Neoplasms (PA445062)</td>
                 <td>irinotecan (PA450085)</td>
                 <td>UGT1A1 (PA420)</td>
                 <td>rs4148323</td>
                 <td>2A</td>
                 <td>GG</td>
                 <td>毒副作用较低</td>
             </tr>
		     <tr>
                 <td>"Carcinoma, Non-Small-Cell Lung (PA443622)"</td>
                 <td>irinotecan (PA450085)</td>
                 <td>ABCC2 (PA116)</td>
                 <td>rs3740066</td>
                 <td>3</td>
                 <td>CC</td>
                 <td>毒副作用可能较高</td>
             </tr>
		     <tr>
                 <td>Colorectal Neoplasms (PA446108)</td>
                 <td>irinotecan (PA450085)</td>
                 <td>UGT1A6 (PA37181)</td>
                 <td>rs2070959</td>
                 <td>3</td>
                 <td>AA</td>
                 <td>毒副作用可能较高</td>
             </tr>
		     <tr>
                 <td>Colorectal Neoplasms (PA446108)</td>
                 <td>irinotecan (PA450085)</td>
                 <td>SLC19A1 (PA327)</td>
                 <td>rs1051266</td>
                 <td>3</td>
                 <td>TT</td>
                 <td>药物敏感性可能较低</td>
             </tr>
		     <tr>
                 <td>Colorectal Neoplasms (PA446108)</td>
                 <td>irinotecan (PA450085)</td>
                 <td>SLCO1B1 (PA134865839)</td>
                 <td>rs2306283</td>
                 <td>3</td>
                 <td>AA</td>
                 <td>药物敏感性可能较高</td>
             </tr>
		     <tr>
                 <td>Neoplasms (PA445062)</td>
                 <td>irinotecan (PA450085)</td>
                 <td>UGT1A1 (PA420)</td>
                 <td>rs4148323</td>
                 <td>3</td>
                 <td>GG</td>
                 <td>药物毒副作用可能较低，敏感性可能较高</td>
             </tr>
		     <tr>
                 <td>"Carcinoma, Non-Small-Cell Lung (PA443622)"</td>
                 <td>irinotecan (PA450085)</td>
                 <td>ABCG2 (PA390)</td>
                 <td>rs2231137</td>
                 <td>3</td>
                 <td>CC</td>
                 <td>毒副作用可能较低</td>
             </tr>
		     <tr>
                 <td>Breast Neoplasms (PA443560)</td>
                 <td>docetaxel (PA449383)</td>
                 <td>ERCC2 (PA27848)</td>
                 <td>rs13181</td>
                 <td>3</td>
                 <td>TT</td>
                 <td>毒副作用可能较高</td>
             </tr>
		     <tr>
                 <td>"Anemia (PA443340),""Nasopharyngeal Neoplasms (PA445046)"""</td>
                 <td>docetaxel (PA449383)</td>
                 <td>NR1I2 (PA378)</td>
                 <td>rs3732359</td>
                 <td>3</td>
                 <td>GG</td>
                 <td>NA</td>
             </tr>
		     <tr>
                 <td>Breast Neoplasms (PA443560)</td>
                 <td>docetaxel (PA449383)</td>
                 <td>ERCC1 (PA155)</td>
                 <td>rs3212986</td>
                 <td>3</td>
                 <td>CC</td>
                 <td>毒副作用可能较高</td>
             </tr>
		     <tr>
                 <td>"Anemia (PA443340),""Nasopharyngeal Neoplasms (PA445046)"""</td>
                 <td>docetaxel (PA449383)</td>
                 <td>NR1I2 (PA378)</td>
                 <td>rs3732360</td>
                 <td>3</td>
                 <td>CC</td>
                 <td>NA</td>
             </tr>
		     <tr>
                 <td>"Anemia (PA443340),""Nasopharyngeal Neoplasms (PA445046)"""</td>
                 <td>docetaxel (PA449383)</td>
                 <td>NR1I2 (PA378)</td>
                 <td>rs3814058</td>
                 <td>3</td>
                 <td>TT</td>
                 <td>毒副作用可能较高</td>
             </tr>
		     <tr>
                 <td>Breast Neoplasms (PA443560)</td>
                 <td>paclitaxel (PA450761)</td>
                 <td>ERCC1 (PA155)</td>
                 <td>rs3212986</td>
                 <td>3</td>
                 <td>CC</td>
                 <td>毒副作用可能较低</td>
             </tr>
		     <tr>
                 <td>"Neoplasms (PA445062),""Neurotoxicity Syndromes (PA446975)"",""Neutropenia (PA445113)"""</td>
                 <td>paclitaxel (PA450761)</td>
                 <td>ABCB1</td>
                 <td>rs1045642</td>
                 <td>3</td>
                 <td>AA</td>
                 <td>毒副作用可能较高</td>
             </tr>
		     <tr>
                 <td>Breast Neoplasms (PA443560)</td>
                 <td>tamoxifen (PA451581)</td>
                 <td>NCOA1 (PA31470)</td>
                 <td>rs1804645</td>
                 <td>3</td>
                 <td>CC</td>
                 <td>毒副作用可能较低</td>
             </tr>
		     <tr>
                 <td>Breast Neoplasms (PA443560)</td>
                 <td>tamoxifen (PA451581)</td>
                 <td>ABCB1 (PA267)</td>
                 <td>rs1045642</td>
                 <td>3</td>
                 <td>AA</td>
                 <td>药物敏感性可能较高</td>
             </tr>
		     <tr>
                 <td>Breast Neoplasms (PA443560)</td>
                 <td>tamoxifen (PA451581)</td>
                 <td>ABCC2 (PA116)</td>
                 <td>rs717620</td>
                 <td>4</td>
                 <td>CC</td>
                 <td>药物敏感性可能较低</td>
             </tr>
		     <tr>
                 <td>Breast Neoplasms (PA443560)</td>
                 <td>tamoxifen (PA451581)</td>
                 <td>CYP2D6 (PA128)</td>
                 <td>rs3892097</td>
                 <td>2A</td>
                 <td>CC</td>
                 <td>敏感性较高，毒副作用较高</td>
             </tr>
		     <tr>
                 <td>"Burkitt Lymphoma (PA443580),""Drug Toxicity (PA443937)"",""Lymphoma, T-Cell (PA446309)"",""Precursor Cell Lymphoblastic Leukemia-Lymphoma (PA446155)"",""Toxic liver disease (PA164925725)"""</td>
                 <td>methotrexate (PA450428)</td>
                 <td>ABCB1 (PA267)</td>
                 <td>rs1045642</td>
                 <td>2A</td>
                 <td>AA</td>
                 <td>毒副作用较高</td>
             </tr>
		     <tr>
                 <td>Neoplasms (PA445062)</td>
                 <td>methotrexate (PA450428)</td>
                 <td>MTHFR (PA245)</td>
                 <td>rs1801133</td>
                 <td>2A</td>
                 <td>GG</td>
                 <td>药物敏感性较高，毒副作用肯较低，</td>
             </tr>
		     <tr>
                 <td>Precursor Cell Lymphoblastic Leukemia-Lymphoma (PA446155)</td>
                 <td>methotrexate (PA450428)</td>
                 <td>"FASTKD3 (PA145148868),""MTRR (PA31277)"""</td>
                 <td>rs1801394</td>
                 <td>2B</td>
                 <td>AA</td>
                 <td>毒副作用可能较低</td>
             </tr>
		     <tr>
                 <td>"Burkitt Lymphoma (PA443580),""Drug Toxicity (PA443937)"",""Lymphoma, T-Cell (PA446309)"",""Precursor Cell Lymphoblastic Leukemia-Lymphoma (PA446155)"",""Toxic liver disease (PA164925725)"""</td>
                 <td>methotrexate (PA450428)</td>
                 <td>ABCB1 (PA267)</td>
                 <td>rs1045642</td>
                 <td>2A</td>
                 <td>AA</td>
                 <td>毒副作用可能较高</td>
             </tr>
		     <tr>
                 <td>Precursor Cell Lymphoblastic Leukemia-Lymphoma (PA446155)</td>
                 <td>methotrexate (PA450428)</td>
                 <td>DHFR (PA143)</td>
                 <td>rs1105525</td>
                 <td>3</td>
                 <td>CC</td>
                 <td>病人生存期较长</td>
             </tr>
		     <tr>
                 <td>Precursor Cell Lymphoblastic Leukemia-Lymphoma (PA446155)</td>
                 <td>methotrexate (PA450428)</td>
                 <td>GGH (PA432)</td>
                 <td>rs11545078</td>
                 <td>3</td>
                 <td>GG</td>
                 <td>毒副作用可能较低</td>
             </tr>
		     <tr>
                 <td>Precursor Cell Lymphoblastic Leukemia-Lymphoma (PA446155)</td>
                 <td>methotrexate (PA450428)</td>
                 <td>CCND1 (PA75)</td>
                 <td>rs9344</td>
                 <td>3</td>
                 <td>GG</td>
                 <td>毒副作用可能较高</td>
             </tr>
		     <tr>
                 <td>"Mesothelioma (PA444937),""Precursor Cell Lymphoblastic Leukemia-Lymphoma (PA446155)"""</td>
                 <td>methotrexate (PA450428)</td>
                 <td>MTHFD1 (PA31236)</td>
                 <td>rs2236225</td>
                 <td>3</td>
                 <td>GG</td>
                 <td>病人的无进展生存期可能较长</td>
             </tr>
		     <tr>
                 <td>"Graft vs Host Disease (PA444320),""Leukemia (PA444750)"",""Leukemia, Myelogenous, Chronic, BCR-ABL Positive (PA446171)"""</td>
                 <td>methotrexate (PA450428)</td>
                 <td>MTHFR (PA245)</td>
                 <td>rs1801133</td>
                 <td>3</td>
                 <td>GG</td>
                 <td>毒副作用可能较高</td>
             </tr>
		     <tr>
                 <td>"Leukemia, B-Cell, Acute (PA446157)"</td>
                 <td>methotrexate (PA450428)</td>
                 <td>ABCC4 (PA397)</td>
                 <td>rs9516519</td>
                 <td>3</td>
                 <td>TT</td>
                 <td>毒副作用可能较高</td>
             </tr>
		 </table>


</body>
</html>